Company profile for Tenpoint Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Tenpoint is a biotechnology company committed to advancing engineered cell-based therapies and in vivo reprogramming to restore vision for people with degenerative ocular diseases, bringing together the global experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. We are addressing the ultimate cause of vision loss by replacing diseased cells with healthy ones to permanent...
Tenpoint is a biotechnology company committed to advancing engineered cell-based therapies and in vivo reprogramming to restore vision for people with degenerative ocular diseases, bringing together the global experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. We are addressing the ultimate cause of vision loss by replacing diseased cells with healthy ones to permanently restore vision. Tenpoint’s global team is united by our passion for science and our commitment to patients.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
30 Broad Street, Cambourne Cambridge CB23 6HJ
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251216294232/en/Tenpoint-Therapeutics-Ltd.-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference-on-January-13-2026

BUSINESSWIRE
16 Dec 2025

https://www.businesswire.com/news/home/20251105608942/en/Tenpoint-Therapeutics-Ltd.-Announces-Submission-of-a-New-Drug-Application-for-BRIMOCHOL-PF-for-the-Treatment-of-Presbyopia-to-the-MFDS-in-South-Korea

BUSINESSWIRE
05 Nov 2025

https://www.pharmiweb.com/press-release/2025-10-13/tenpoint-therapeutics-ltd-to-participate-in-four-upcoming-investor-conferences

PHARMIWEB
13 Oct 2025

https://www.pharmiweb.com/press-release/2025-09-08/tenpoint-therapeutics-ltd-to-participate-in-upcoming-eye-care-conferences

PHARMAWEB
08 Sep 2025

https://www.pharmiweb.com/press-release/2025-08-25/tenpoint-therapeutics-ltd-to-participate-in-investor-conferences-in-september

PHARMAWEB
25 Aug 2025

https://www.businesswire.com/news/home/20250804817770/en/Tenpoint-Therapeutics-Ltd.-to-Participate-in-Upcoming-Investor-Conferences-in-August

BUSINESSWIRE
04 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty